2696 — Shanghai Henlius Biotech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual cashflow statement for Shanghai Henlius Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-957	-694	570	846	812
Depreciation
Amortisation
Non-Cash Items	336	299	161	106	237
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	511	1,099	-41.8	-84.9	-173
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	90.4	982	1,048	1,242	1,306
Capital Expenditures	-1,131	-1,365	-1,011	-837	-1,200
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-550	6.56	7.01	-72.8	3.59
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,681	-1,359	-1,004	-910	-1,196
Financing Cash Flow Items	-83.4	-115	-130	-133	58.7
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	648	858	144	-643	-93.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-959	518	194	-296	7.81